Multidisciplinary Audit of Hypertensive Disorders in Pregnancy with Autoimmune Comorbidities and Manifestations: Maternal, Fetal, Musculoskeletal, and Physiological Outcomes from a Cohort Study

Authors

  • Fauzia Dilshad, Priya Malhotra, Attiq ur Rehman, Nargis Haider, Aks-e Taqveen, Muhammad Azhar Khan

Keywords:

hypertensive disorders of pregnancy, autoimmune comorbidity, preeclampsia, fetal growth restriction, maternal outcomes

Abstract

Severe hypertensive disorders in pregnancy (HDP) coexisting with autoimmune disease present acomplex clinical phenotype with multisystem consequences that span maternal, fetal,musculoskeletal and physiological domains.

References

Liu Y, Wei Y, Zhang Y, Yang H. Hydroxychloroquine significantly decreases the risk of preeclampsia in pregnant women with autoimmune disorders: a systematic review and meta-analysis. Clin Rheumatol. 2023;42(5):1223–1235. doi:10.1007/s10067-022-064962.

Downloads

Published

2025-10-24

How to Cite

Fauzia Dilshad, Priya Malhotra, Attiq ur Rehman, Nargis Haider, Aks-e Taqveen, Muhammad Azhar Khan. (2025). Multidisciplinary Audit of Hypertensive Disorders in Pregnancy with Autoimmune Comorbidities and Manifestations: Maternal, Fetal, Musculoskeletal, and Physiological Outcomes from a Cohort Study. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 2628–2639. Retrieved from https://www.ijprt.org/index.php/pub/article/view/1098

Issue

Section

Research Article